Glucose-induced (physiological) insulin secretion from the islet β-cell involves interplay between cationic (i.e., changes in intracellular calcium) and metabolic (i.e., generation of hydrophobic and hydrophilic second messengers) events. A large body of evidence affirms support for novel regulation, by G proteins, of specific intracellular signaling events, including actin cytoskeletal remodeling, transport of insulin-containing granules to the plasma membrane for fusion, and secretion of insulin into the circulation. This article highlights the following aspects of GPCR-G protein biology of the islet. First, it overviews our current understanding of the identity of a wide variety of G protein regulators and their modulatory roles in GPCR-G protein-effector coupling, which is requisite for optimal β-cell function under physiological conditions. Second, it describes evidence in support of novel, noncanonical, GPCR-independent mechanisms of activation of G proteins in the islet. Third, it highlights the evidence indicating that abnormalities in G protein function lead to islet β-cell dysregulation and demise under the duress of metabolic stress and diabetes. Fourth, it summarizes observations of potential beneficial effects of GPCR agonists in preventing/halting metabolic defects in the islet β-cell under various pathological conditions (e.g., metabolic stress and inflammation). Lastly, it identifies knowledge gaps and potential avenues for future research in this evolving field of translational islet biology. Published 2020. Compr Physiol 10:453-490, 2020.
Didactic Synopsis Major teaching points• A large number of GPCRs are expressed in rodent islets and human islets, and they communicate with trimeric G proteins with high degree of specificity.• In addition to GPCR-mediated regulation, G proteins are activated via noncanonical mechanisms.• Activation of GPCR-G protein modules leads to regulation of specific effector proteins, leading to the generation of appropriate second messengers, which are essential for physiological insulin secretion.• GPCR-G protein signaling pathways also regulate functions of monomeric G proteins, which play essential roles in cytoskeletal remodeling and vesicular fusion and insulin exocytosis.• (In)activation of trimeric and monomeric G proteins is facilitated by highly specific regulatory proteins/factors as well as by specific posttranslational modifications.• Metabolic stress promotes aberrant activation and inappropriate localization of G proteins, leading to cell dysfunction and demise.• Agonists of GPCRs afford protection against β-cell dysfunction observed in in vitro and in vivo models of metabolic stress and diabetes.